The effects of repeated doses of xylazine-ketamine and medetomidine- ketamine anesthesia on DNA damage in the liver and kidney
dc.contributor.author | Sancak, Tunahan | |
dc.date.accessioned | 2024-10-26T18:02:11Z | |
dc.date.available | 2024-10-26T18:02:11Z | |
dc.date.issued | 2023 | |
dc.department | Sivas Cumhuriyet Üniversitesi | |
dc.description.abstract | Purpose: This study evaluated the DNA damage caused by repeated doses of xylazine-ketamine and medetomidine-ketamine anesthesia in the liver and kidneys.Methods: In this study, 60 rats were used. The rats were divided into group 1 (xylazine-ketamine), and group 2 (medetomidine-ketamine), and these anesthetic combinations were administered to the rats at repeated doses with 30-min intervals. The effects of these anesthetic agents on the tumor necrosis factor-alpha gene for DNA damage were investigated.Results: According to the gene expression results, it was observed that a single dose of xylazine-ketamine was 2.9-fold expressed, while first and second repeat doses did not show significant changes in expression levels. However, in the case of the third repetition, it was observed to be 3.8-fold overexpressed. In the case of medetomidine-ketamine administration, it was observed that a single-dose application resulted in a 1.04-fold expression, while the first and the third repeat doses showed a significant down expression. The samples from the second repeat dose administration group were found to have insignificant levels of expression.Conclusion: This study can contribute to understanding the safe anesthetic combination in research and operations in which xylazine-ketamine and medetomidine-ketamine combinations are used. | |
dc.identifier.doi | 10.1590/acb385723 | |
dc.identifier.issn | 0102-8650 | |
dc.identifier.issn | 1678-2674 | |
dc.identifier.pmid | 37909595 | |
dc.identifier.scopus | 2-s2.0-85175546828 | |
dc.identifier.scopusquality | Q3 | |
dc.identifier.uri | https://doi.org/10.1590/acb385723 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12418/27983 | |
dc.identifier.volume | 38 | |
dc.identifier.wos | WOS:001096086400001 | |
dc.identifier.wosquality | Q3 | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | PubMed | |
dc.language.iso | en | |
dc.publisher | Acta Cirurgica Brasileira | |
dc.relation.ispartof | Acta Cirurgica Brasileira | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.subject | Anesthesia | |
dc.subject | DNA Damage | |
dc.subject | Gene Expression | |
dc.subject | Repeated Dose | |
dc.subject | Tumor Necrosis Factor-alpha | |
dc.title | The effects of repeated doses of xylazine-ketamine and medetomidine- ketamine anesthesia on DNA damage in the liver and kidney | |
dc.type | Article |